Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Neoplasma|January 1, 1991
Secondary neoplasms following cancer treatment with a special emphasis on lung tumorsJ Klastersky, A LeleuxCell Reports|January 19, 2017
Biophysical Attributes of CpG Presentation Control TLR9 Signaling to Differentially Polarize Systemic Immune ResponsesJardin A Leleux, Pallab Pradhan, Krishnendu RoyActa Clinica Belgica|May 23, 2002
[Hypokalemic thyrotoxic periodic paralysis: a case report]F Vandergheynst, A Vandergheynst, A Leleux, et al.ACS Biomaterials Science & Engineering|January 16, 2021
Surface-Presentation of CpG and Protein-Antigen on Pathogen-Like Polymer Particles Generate Strong Prophylactic and Therapeutic Antitumor ProtectionEileen Dawson, Jardin A Leleux, Pallab Pradhan, et al.Revue Medicale De Bruxelles|December 1, 1989
[Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer]R Snoeck, J Gerain, A Leleux, et al.Presse Medicale (Paris, France : 1983)|January 7, 1989
[Prevention using pefloxacin of infections in cancer patients with granulocytopenia]A Leleux, R Snoeck, J Gerain, et al.Vaccine|August 24, 2020
ZVex™, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalitiesJardin A Leleux, Tina C Albershardt, Andrea J Parsons, et al.Biomaterials|April 12, 2014
The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphomaPallab Pradhan, Hong Qin, Jardin A Leleux, et al.Plos One|December 2, 2021
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memoryJardin A Leleux, Tina C Albershardt, Rebecca Reeves, et al.Oncology|February 17, 2005
Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II studyJ-L Van Laethem, Ph Van Maele, C Verslype, et al.Pageof 1